Sector Alpha Week of 2026-09-19
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-19

Honeywell Aerospace Inc.

HONA
Industrials · Aerospace & Defense

Honeywell Aerospace Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.

The price is between stages. Underneath, the last four quarters read deteriorating — profit −69.4% year on year, and 109% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.

Price
$164
P/E
26.6×
vs its own history
Revenue (Jun 26)
$4.5 B
+5.4% YoY
Profit (Jun 26)
$0.3 B
−69.4% YoY
Operating margin
12.8%
−10.5 pp YoY
ROIC
18.3%
Cash conversion
109%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Honeywell Aerospace Inc. trades at $164, between stages. It sits at 5% of a 52-week range of $158 to $268. On relative strength it has no relative-strength read yet.

Today the stock is between stages. At $164 it trades near its long-run average and sits at 5% of its 52-week range ($158–$268).

Sep 26: $164 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 1-year window.
week — of stage —
Price50-day avg
$277$245$213$181$149$$164Jun 26Jul 26Jul 26Aug 26Sep 26
$277$245$213$181$149$$164Jun 26Jul 26Sep 26

Against the market, two honest reads. Cumulative: over the last 4 months the stock moved −39% while the S&P 500 moved +2% — behind the index over the full window. Recent form: no trailing-13-week read yet — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

Honeywell Aerospace Inc. trades at 26.6× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 26.6× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E
26.6×
too little history to rank
PEG
1.83
as reported

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Honeywell Aerospace Inc. reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 6 quarters across 0 curves, on partial evidence.

Growth, year by year: revenue +12.6% in FY25, profit −4.6% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoY
12.6%−1.9%12.5%−2.6%12.3%−3.3%12.1%−4.1%12.0%−4.8%%%12.6%−4.6%FY23FY24FY25
12.6%−1.9%12.5%−2.6%12.3%−3.3%12.1%−4.1%12.0%−4.8%%%12.6%−4.6%FY23FY24FY25
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Where the trailing-twelve-month history is short, the curve falls back to single-quarter year-on-year growth — noisier, and the classifier smooths and caps base-effect spikes before reading. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from
RevenueProfit
18%20%14%−4.1%11%−28%7.8%−52%4.5%−76%%%5.4%−69.4%Mar 24Mar 25Jun 26
18%20%14%−4.1%11%−28%7.8%−52%4.5%−76%%%5.4%−69.4%Mar 24Mar 25Jun 26

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

The return-on-capital curve is not shown — net worth is negative, so a return on capital is not a meaningful number in any basis. This is a distressed balance sheet, and the stage is read from the growth curves alone.

One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+12.6%
Profit−4.6%
Revenue YoY (Jun 26)
+5.4%
latest quarter vs a year ago
Profit YoY (Jun 26)
−69.4%
latest quarter vs a year ago
Revenue 10y
12.3%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

42.9/100 — rank 29 of 30 in Aerospace & Defense · 48% evidence confidence · provisional, ranked below fully-evidenced peers

Honeywell Aerospace Inc. scores 42.9 out of 100 against the 30 companies it is compared with in Aerospace & Defense, ranking 29. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

The four contributions add to the total exactly: 7.3 + 15.6 + 10 + 10 = 42.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Honeywell Aerospace Inc. reported $4.5 B of revenue in the Jun 26 quarter, +5.4% year on year. That is the 6th straight quarter of year-on-year growth. Over 2 years it has compounded at 12.3% a year. The last full year, FY25, came in at $17.4 B. The last four reported quarters add to $17.9 B.

FY25 revenue came in at $17.4 B (+12.6% on the year), capping 2 years at 12.3% compound. The latest quarter (Jun 26) printed $4.5 B, +5.4% year on year — the 6th consecutive quarter of year-over-year growth.

FY25 revenue $17.4 B (+12.6% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 3-year window. A bar is red when it is lower than the year before.
12.3% a year over 2 years
RevenueYoY growth
1912.6%1412.5%9.412.3%4.712.1%0.012.0%$ B%$17B12.6%FY23FY24FY25
1912.6%1412.5%9.412.3%4.712.1%0.012.0%$ B%$17B12.6%FY23FY24FY25
Jun 26: $4.5 B (+5.4% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
6th straight quarter of growth
Revenue (quarterly)YoY growth
4.918%3.714%2.411%1.27.8%0.04.5%$ B%$5B5.4%Mar 24Mar 25Jun 26
4.918%3.714%2.411%1.27.8%0.04.5%$ B%$5B5.4%Mar 24Mar 25Jun 26

Pace check: the last four quarters averaged +10.3% growth against the decade's 12.3% — the current year is running slower than its own long-run rate.

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Honeywell Aerospace Inc.'s operating margin is 12.8% in the Jun 26 quarter, −10.5 percentage points against the same quarter a year ago. Across 3 fiscal years the operating margin has ranged 19.3% to 25.2%. The current quarter is running below every full year in that window.

The latest quarter's operating margin is 12.8%, −10.5 pp against the same quarter a year ago. Across 3 fiscal years the operating margin has ranged 19.3%–25.2%.

🚨 Why the margin moved: operating margin went −10.5 pp year on year while gross margin went −1.4 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

FY25: 19.3% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 3-year window.
within a 19.3–25.2% band over 3 years
operating marginYoY change (pp)
26%−2.4%24%−2.7%22%−3.0%21%−3.2%19%−3.5%%%19.3%−2.5%FY23FY24FY25
26%−2.4%24%−2.7%22%−3.0%21%−3.2%19%−3.5%%%19.3%−2.5%FY23FY24FY25
Jun 26: 12.8% operating margin (−10.5 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
26%1.3%23%−1.9%19%−5.0%15%−8.2%12%−11%%%12.8%−10.5%Mar 24Mar 25Jun 26
26%1.3%23%−1.9%19%−5.0%15%−8.2%12%−11%%%12.8%−10.5%Mar 24Mar 25Jun 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Honeywell Aerospace Inc. earned $0.3 B of net profit in the Jun 26 quarter, −69.4% year on year. Full-year FY25 profit was $2.7 B. The 2-year compound rate is −3.3%. That is 5.8% of the quarter's revenue. The same quarter a year earlier earned $0.8 B.

Jun 26 profit was $0.3 B, −69.4% year on year. On the full year, FY25 printed $2.7 B (−4.6%), and the 2-year compound rate is −3.3%.

FY25 profit $2.7 B (−4.6% YoY) Net profit bars, $ B (left); YoY growth-% line (right). 3-year window. A bar is red when it is lower than the year before.
−3.3% a year over 2 years
Net profitYoY growth
3.1−1.9%2.4−2.6%1.6−3.3%0.8−4.1%0.0−4.8%$ B%$3B−4.6%FY23FY24FY25
3.1−1.9%2.4−2.6%1.6−3.3%0.8−4.1%0.0−4.8%$ B%$3B−4.6%FY23FY24FY25
Jun 26: $0.3 B (−69.4% YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
0.920%0.7−4.1%0.5−28%0.2−52%0.0−76%$ B%$0B−69.4%Mar 24Mar 25Jun 26
0.920%0.7−4.1%0.5−28%0.2−52%0.0−76%$ B%$0B−69.4%Mar 24Mar 25Jun 26

🚨 Why profit moved: revenue contributed +5.4% and the margin −10.5 pp — the quarter was revenue-led despite a thinner margin.

Pace comparison, last four quarters: profit −31.3% vs revenue +10.3%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 109% of Honeywell Aerospace Inc.'s reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $3.7 B of operating cash against $2.7 B of profit. After $0.5 B of capital spending, $3.2 B was left as free cash.

FY25: operating cash of $3.7 B against reported profit of $2.7 B, leaving free cash of $3.2 B after $0.5 B of capital spending. Across the last 3 fiscal years the conversion rate is 109% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY25: CFO $3.7 B vs profit $2.7 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 3-year window, annual resolution.
109% of 3-year profit arrived as cash
Operating cashNet profitFree cash
4.03.02.01.00.0$ B$4B$3B$3BFY23FY24FY25
4.03.02.01.00.0$ B$4B$3B$3BFY23FY24FY25
Jun 26: operating cash $0.6 B = 219% of the quarter's profit Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 6 quarters. Dashed line = 100%.
Operating cash (quarterly)Conversion100%
1.5340%1.0239%0.6138%0.137%−0.4−64%$ B%$1B219%Mar 25Sep 25Jun 26
1.5340%1.0239%0.6138%0.137%−0.4−64%$ B%$1B219%Mar 25Sep 25Jun 26

Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Honeywell Aerospace Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $1.0 B over the last 3 years. Averaged over those years that is 1.9% of FY25 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $1.0 B over the last 3 fiscal years.

FY25: capex $0.5 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
0.50.40.30.10.0$ B$1BFY23FY24FY25
0.50.40.30.10.0$ B$1BFY23FY24FY25
Jun 26: capex $0.1 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 6 quarters.
Capex (quarterly)Free cash
0.151.30.110.90.080.40.040.00.00−0.5$ B$ B$0B$1BMar 25Sep 25Jun 26
0.151.30.110.90.080.40.040.00.00−0.5$ B$ B$0B$1BMar 25Sep 25Jun 26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

Honeywell Aerospace Inc. earns a ROE of 32% in FY25. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 15.6% net margin on 0.98× asset turns.

FY25 ROE is 32%.

Why the return is what it is — the wiring (FY25): 15.6% net margin × 0.98× asset turns × 2.08× balance-sheet leverage ≈ 31.8% on equity. Margin is doing the heavy lifting; leverage is a meaningful part of the equation.

FY25: ROE 32% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 2-year window, dips included.
the full ladder
ROEROIC (annual)
33.3%32.9%32.6%32.3%31.9%%32%32.3%FY24FY25
33.3%32.9%32.6%32.3%31.9%%32%32.3%FY24FY25
Jun 26: ROIC 22.4% (TTM) Trailing-twelve-month ROIC and ROE, per quarter, %. Last 6 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)
33%18%2.6%−12%−27%%22.4%−9.1%Sep 24Sep 25Jun 26
33%18%2.6%−12%−27%%22.4%−9.1%Sep 24Sep 25Jun 26
11 · Dividend

Dividend

Honeywell Aerospace Inc. pays no dividend. Across the last 10 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.

Honeywell Aerospace Inc. does not currently pay a dividend. Across the last 10 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.

12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Honeywell Aerospace Inc.'s net worth is negative — it owes more than it owns — so a debt-to-equity ratio is not meaningful here. On the annual view that ratio went from 0.00 in FY24 to 0.00 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.

Jun 26: total debt of $15.8 B against shareholder equity of $−5.6 B — a debt-to-equity of −2.82. On the annual view, debt-to-equity went from 0.00 (FY24) to 0.00 (FY25). The returns on this page are earned, not borrowed.

FY25: debt $0.0 B at 0.00× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 2-year window.
Total debtDebt-to-equity
1.21.2×0.60.6×0.00.0×−0.6−0.6×−1.2−1.2×$ B×$0B0.00×FY24FY25
1.21.2×0.60.6×0.00.0×−0.6−0.6×−1.2−1.2×$ B×$0B0.00×FY24FY25
Jun 26: debt $15.8 B, debt-to-equity −2.82 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 7 quarters.
Total debt (quarterly)Debt-to-equity
170.3×13−0.6×8.6−1.4×4.3−2.3×0.0−3.1×$ B×$16B−2.82×Sep 24Sep 25Jun 26
170.3×13−0.6×8.6−1.4×4.3−2.3×0.0−3.1×$ B×$16B−2.82×Sep 24Sep 25Jun 26
13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

1.5% of Honeywell Aerospace Inc.'s tradable float is currently sold short — the crowd is not positioned against this stock. At typical trading volumes those positions would take about 1.0 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 1.5% of the float is sold short, and at typical trading volumes it would take about 1.0 days to buy those positions back. The crowd is not positioned against this stock. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
1.5%
of the tradable float
Days to cover
1.0
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Honeywell Aerospace Inc.: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

15 · Related companies · Aerospace & Defense
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Lockheed Martin CorporationLMT 72.1/100Favorable setup81% evidence TURNING 25.8/35 Revenue 7.2% · PAT 49.5% · OPM change 8.3 pp 83% evidence 14.6/25 ROCE 6.8% · OPM 12.4% 76% evidence 16.1/20 P/E 18.7× · PEG 0.35 65% evidence 15.6/20 RS sector 5.3% · RS bench -9.6% · 1Y 12.8%4 of 12 weeks ahead 100% evidence
Exact sum: 25.8 + 14.6 + 16.1 + 15.6 = 72.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2RTX CorporationRTX 65.6/100Favorable setup81% evidence FADING 21.7/35 Revenue 11.8% · PAT 26.1% · OPM change 1.2 pp 83% evidence 15.3/25 ROCE 10.4% · OPM 12.7% 76% evidence 12.1/20 P/E 33× · PEG 1.33 65% evidence 16.5/20 RS sector 10% · RS bench -5.1% · 1Y 22.6%7 of 12 weeks ahead 100% evidence
Exact sum: 21.7 + 15.3 + 12.1 + 16.5 = 65.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3Elbit Systems Ltd.ESLT 60.8/100Mixed-positive evidence81% evidence ASLEEP 22.7/35 Revenue 13.7% · PAT 60.2% · OPM change 1.6 pp 83% evidence 11.5/25 ROCE 3.1% · OPM 9.6% 76% evidence 11.6/20 P/E 57.2× · PEG 1.13 65% evidence 15.0/20 RS sector 13.9% · RS bench -2.2% · 1Y 52.3%1 of 12 weeks ahead 100% evidence
Exact sum: 22.7 + 11.5 + 11.6 + 15 = 60.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Howmet Aerospace Inc.HWM 60.4/100Mixed-positive evidence81% evidence ASLEEP 24.9/35 Revenue 18.1% · PAT 33.9% · OPM change 2.5 pp 83% evidence 16.3/25 ROCE 7% · OPM 27.9% 76% evidence 8.9/20 P/E 57.9× · PEG 1.62 65% evidence 10.3/20 RS sector 4.3% · RS bench -9.9% · 1Y 20.7%3 of 12 weeks ahead 100% evidence
Exact sum: 24.9 + 16.3 + 8.9 + 10.3 = 60.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5HEICO CorporationHEI 60.4/100Mixed-positive evidence81% evidence ASLEEP 24.6/35 Revenue 18.8% · PAT 30.2% · OPM change 2.9 pp 83% evidence 14.4/25 ROCE 4.3% · OPM 25.5% 76% evidence 10.3/20 P/E 48.2× · PEG 1.56 65% evidence 11.1/20 RS sector -0.4% · RS bench -13.9% · 1Y -6.4%8 of 12 weeks ahead 100% evidence
Exact sum: 24.6 + 14.4 + 10.3 + 11.1 = 60.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Embraer S.A.EMBJ 58.4/100Mixed-positive evidence66% evidence BREAKING OUT 16.6/35 Revenue 20% · PAT -22.2% · OPM change 1 pp 53% evidence 7.7/25 ROCE 1.1% · OPM 5.6% 57% evidence 14.1/20 P/E 54.9× · PEG 0.51 65% evidence 20.0/20 RS sector 23.6% · RS bench 6.8% · 1Y 29.6%8 of 12 weeks ahead 100% evidence
Exact sum: 16.6 + 7.7 + 14.1 + 20 = 58.4 · Decision use: Price leads the evidence: RS versus the benchmark is 6.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
7General Dynamics CorporationGD 56.1/100Thin evidence · provisional58% evidence ASLEEP 16.9/35 Revenue — · PAT — · OPM change 0.1 pp 45% evidence 12.3/25 ROCE 3.7% · OPM 10.4% 76% evidence 11.0/20 P/E 22.8× · PEG — 15% evidence 15.9/20 RS sector 7.4% · RS bench -7.1% · 1Y 8.9%6 of 12 weeks ahead 100% evidence
Exact sum: 16.9 + 12.3 + 11 + 15.9 = 56.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
8GE AerospaceGE 55.3/100Mixed-positive evidence81% evidence ASLEEP 19.5/35 Revenue 21.7% · PAT 16.2% · OPM change -0.3 pp 83% evidence 16.4/25 ROCE 11.7% · OPM 20.6% 76% evidence 7.2/20 P/E 43.5× · PEG 2.38 65% evidence 12.2/20 RS sector 6.1% · RS bench -8.3% · 1Y 4.4%8 of 12 weeks ahead 100% evidence
Exact sum: 19.5 + 16.4 + 7.2 + 12.2 = 55.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9Hexcel CorporationHXL 54.0/100Thin evidence · provisional56% evidence FADING 20.8/35 Revenue — · PAT — · OPM change 1.8 pp 39% evidence 10.6/25 ROCE 2.9% · OPM 11.5% 76% evidence 9.9/20 P/E 50.3× · PEG — 15% evidence 12.7/20 RS sector 11.4% · RS bench -3.7% · 1Y 42.5%7 of 12 weeks ahead 100% evidence
Exact sum: 20.8 + 10.6 + 9.9 + 12.7 = 54 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
10Curtiss-Wright CorporationCW 53.3/100Mixed-positive evidence81% evidence ASLEEP 21.9/35 Revenue 10.5% · PAT 20% · OPM change 1.5 pp 83% evidence 19.6/25 ROCE 17.4% · OPM 19.4% 76% evidence 7.3/20 P/E 51.7× · PEG 2.28 65% evidence 4.5/20 RS sector -5.9% · RS bench -19% · 1Y 10.4%0 of 12 weeks ahead 100% evidence
Exact sum: 21.9 + 19.6 + 7.3 + 4.5 = 53.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Woodward, Inc.WWD 52.8/100Thin evidence · provisional56% evidence ASLEEP 20.3/35 Revenue — · PAT — · OPM change 1.2 pp 39% evidence 14.1/25 ROCE 4.9% · OPM 14.7% 76% evidence 9.8/20 P/E 50.5× · PEG — 15% evidence 8.6/20 RS sector 1.6% · RS bench -12.5% · 1Y 35.1%1 of 12 weeks ahead 100% evidence
Exact sum: 20.3 + 14.1 + 9.8 + 8.6 = 52.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
12Leonardo DRS, Inc.DRS 49.9/100Thin evidence · provisional56% evidence ASLEEP 20.3/35 Revenue — · PAT — · OPM change 1.7 pp 39% evidence 11.6/25 ROCE 3.3% · OPM 9.1% 76% evidence 10.7/20 P/E 35.9× · PEG — 15% evidence 7.3/20 RS sector -3% · RS bench -16.5% · 1Y -10.3%2 of 12 weeks ahead 100% evidence
Exact sum: 20.3 + 11.6 + 10.7 + 7.3 = 49.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
13Textron Inc.TXT 45.6/100Thin evidence · provisional56% evidence ASLEEP 15.9/35 Revenue — · PAT — · OPM change -0.8 pp 39% evidence 9.1/25 ROCE 2% · OPM 6.3% 76% evidence 11.3/20 P/E 17.4× · PEG — 15% evidence 9.3/20 RS sector -3.4% · RS bench -16.8% · 1Y -4.7%1 of 12 weeks ahead 100% evidence
Exact sum: 15.9 + 9.1 + 11.3 + 9.3 = 45.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
14Northrop Grumman CorporationNOC 45.5/100Mixed-negative evidence81% evidence BASING 10.3/35 Revenue 5.9% · PAT 14% · OPM change -3.7 pp 83% evidence 10.6/25 ROCE 3% · OPM 10.1% 76% evidence 14.5/20 P/E 16.2× · PEG 1.01 65% evidence 10.1/20 RS sector -5.4% · RS bench -18.8% · 1Y -8%0 of 12 weeks ahead 100% evidence
Exact sum: 10.3 + 10.6 + 14.5 + 10.1 = 45.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
15The Boeing CompanyBA 44.0/100Mixed-negative evidence64% evidence ASLEEP 19.9/35 Revenue 24.8% · PAT — · OPM change 1.4 pp 62% evidence 4.2/25 ROCE 0.3% · OPM 0.6% 76% evidence 9.0/20 P/E 93.7× · PEG — 15% evidence 10.9/20 RS sector -2.3% · RS bench -15.8% · 1Y -8.1%0 of 12 weeks ahead 100% evidence
Exact sum: 19.9 + 4.2 + 9 + 10.9 = 44 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16CAE Inc.CAE 43.9/100Mixed-negative evidence66% evidence ASLEEP 10.8/35 Revenue 4.4% · PAT -22.4% · OPM change -7.6 pp 53% evidence 10.6/25 ROCE 2% · OPM 12.9% 57% evidence 14.7/20 P/E 37.3× · PEG 0.68 65% evidence 7.8/20 RS sector -7.6% · RS bench -20.5% · 1Y -15.7%0 of 12 weeks ahead 100% evidence
Exact sum: 10.8 + 10.6 + 14.7 + 7.8 = 43.9 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
17Huntington Ingalls Industries, Inc.HII 43.4/100Thin evidence · provisional56% evidence BASING 16.5/35 Revenue — · PAT — · OPM change -0.9 pp 39% evidence 9.1/25 ROCE 2.2% · OPM 5% 76% evidence 11.4/20 P/E 16.7× · PEG — 15% evidence 6.4/20 RS sector -12.8% · RS bench -25.3% · 1Y -0.8%0 of 12 weeks ahead 100% evidence
Exact sum: 16.5 + 9.1 + 11.4 + 6.4 = 43.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
18Axon Enterprise, Inc.AXON 43.0/100Mixed-negative evidence71% evidence FADING 20.0/35 Revenue 34.6% · PAT -39% · OPM change 5.4 pp 83% evidence 6.4/25 ROCE 0.9% · OPM 5.2% 76% evidence 8.6/20 P/E 232.6× · PEG — 15% evidence 8.0/20 RS sector -9.7% · RS bench -21.8% · 1Y -42.2%10 of 12 weeks ahead 100% evidence
Exact sum: 20 + 6.4 + 8.6 + 8 = 43 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19TransDigm Group IncorporatedTDG 42.6/100Mixed-negative evidence81% evidence ASLEEP 15.5/35 Revenue 16.6% · PAT 10.3% · OPM change -1.6 pp 83% evidence 15.9/25 ROCE 5.5% · OPM 44.8% 76% evidence 5.3/20 P/E 40.2× · PEG 4.28 65% evidence 5.9/20 RS sector -8.3% · RS bench -20.9% · 1Y -15.3%0 of 12 weeks ahead 100% evidence
Exact sum: 15.5 + 15.9 + 5.3 + 5.9 = 42.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20StandardAero, Inc.SARO 41.9/100Thin evidence · provisional56% evidence ASLEEP 18.4/35 Revenue 15% · PAT 100% · OPM change -0.2 pp 53% evidence 9.1/25 ROCE 2.8% · OPM 8.8% 57% evidence 10.9/20 P/E 29.4× · PEG — 15% evidence 3.5/20 RS sector -13% · RS bench -25.1% · 1Y -19.1%4 of 12 weeks ahead 100% evidence
Exact sum: 18.4 + 9.1 + 10.9 + 3.5 = 41.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
21Rocket Lab CorporationRKLB 41.8/100Mixed-negative evidence61% evidence ASLEEP 25.2/35 Revenue 52.6% · PAT — · OPM change 16.7 pp 62% evidence 3.2/25 ROCE -2.4% · OPM -24.6% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 3.4/20 RS sector -7.4% · RS bench -20.2% · 1Y 35.1%2 of 12 weeks ahead 100% evidence
Exact sum: 25.2 + 3.2 + 10 + 3.4 = 41.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -7.4% and the one-year return is 35.1%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
22L3Harris Technologies, Inc.LHX 39.7/100Thin evidence · provisional58% evidence ASLEEP 17.3/35 Revenue — · PAT — · OPM change 0.6 pp 45% evidence 10.0/25 ROCE 1.9% · OPM 11.1% 76% evidence 8.9/20 P/E 96× · PEG — 15% evidence 3.5/20 RS sector -13.5% · RS bench -25.8% · 1Y -12.9%0 of 12 weeks ahead 100% evidence
Exact sum: 17.3 + 10 + 8.9 + 3.5 = 39.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
23FTAI Aviation Ltd.FTAI 39.0/100Thin evidence · provisional56% evidence ASLEEP 12.9/35 Revenue — · PAT — · OPM change -9.6 pp 39% evidence 13.3/25 ROCE 5% · OPM 20.5% 76% evidence 9.1/20 P/E 58.8× · PEG — 15% evidence 3.7/20 RS sector -6.9% · RS bench -20.3% · 1Y 6.6%0 of 12 weeks ahead 100% evidence
Exact sum: 12.9 + 13.3 + 9.1 + 3.7 = 39 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
24AeroVironment, Inc.AVAV 38.0/100Mixed-negative evidence71% evidence BASING 17.6/35 Revenue 100% · PAT -702.3% · OPM change 3.9 pp 83% evidence 6.1/25 ROCE 1.8% · OPM 8.9% 76% evidence 8.7/20 P/E 97.8× · PEG — 15% evidence 5.6/20 RS sector -26.3% · RS bench -36.7% · 1Y -42.6%2 of 12 weeks ahead 100% evidence
Exact sum: 17.6 + 6.1 + 8.7 + 5.6 = 38 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25Kratos Defense & Security Solutions, Inc.KTOS 37.8/100Thin evidence · provisional56% evidence ASLEEP 18.4/35 Revenue 21.9% · PAT 50% · OPM change -0.9 pp 53% evidence 6.5/25 ROCE 0.2% · OPM 1.3% 57% evidence 8.5/20 P/E 423.2× · PEG — 15% evidence 4.4/20 RS sector -29.8% · RS bench -40.1% · 1Y -41.2%1 of 12 weeks ahead 100% evidence
Exact sum: 18.4 + 6.5 + 8.5 + 4.4 = 37.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
26BWX Technologies, Inc.BWXT 34.4/100Adverse evidence66% evidence ASLEEP 16.7/35 Revenue 21.4% · PAT 19% · OPM change -1.8 pp 53% evidence 11.1/25 ROCE 2.7% · OPM 9.9% 57% evidence 5.2/20 P/E 54.7× · PEG 2.86 65% evidence 1.4/20 RS sector -17% · RS bench -28.7% · 1Y -15.5%0 of 12 weeks ahead 100% evidence
Exact sum: 16.7 + 11.1 + 5.2 + 1.4 = 34.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Moog Inc.MOG-B 52.9/100Thin evidence · provisional33% evidence FADING 19.5/35 Revenue — · PAT — · OPM change 1 pp 32% evidence 12.9/25 ROCE 4.4% · OPM 10.8% 76% evidence 10.5/20 P/E 36.1× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y 84.3%9 of 11 weeks ahead 0% evidence
Exact sum: 19.5 + 12.9 + 10.5 + 10 = 52.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
28DPC Holdings PLCDPC 46.9/100Thin evidence · provisional16% evidence 16.5/35 Revenue — · PAT — · OPM change — 6% evidence 10.4/25 ROCE 5.3% · OPM 8.4% 57% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence
Exact sum: 16.5 + 10.4 + 10 + 10 = 46.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
29Honeywell Aerospace Inc.this pageHONA 42.9/100Thin evidence · provisional48% evidence ASLEEP 7.3/35 Revenue 10.1% · PAT -32.7% · OPM change -10.5 pp 83% evidence 15.6/25 ROCE 8.9% · OPM 12.8% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y —0 of 1 week ahead 0% evidence
Exact sum: 7.3 + 15.6 + 10 + 10 = 42.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
30Space Exploration Technologies Corp.SPCX 40.0/100Thin evidence · provisional33% evidence ASLEEP 16.6/35 Revenue — · PAT — · OPM change 17.2 pp 39% evidence 3.4/25 ROCE -1.6% · OPM -1.8% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y —0 of 1 week ahead 0% evidence
Exact sum: 16.6 + 3.4 + 10 + 10 = 40 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is Honeywell Aerospace Inc.'s stock price today?

Honeywell Aerospace Inc. trades at $164. The company is valued at $52.0 B. The stock sits at 5% of its 52-week range of $158–$268. — as of 19 September 2026.

What were Honeywell Aerospace Inc.'s latest quarterly results?

Honeywell Aerospace Inc. reported revenue of $4.5 B and net profit of $0.3 B for the Jun 26 quarter. Revenue rose 5.4% and profit fell 69.4% year on year. Earnings per share were $0.78. The operating margin was 12.8%, 10.5 pp lower than a year earlier. — as of 19 September 2026.

What is Honeywell Aerospace Inc.'s revenue?

Honeywell Aerospace Inc. reported revenue of $4.5 B in the Jun 26 quarter, +5.4% year on year. For the full FY25 fiscal year, revenue was $17.4 B (+12.6%). Over the last 2 years revenue compounded at 12.3% a year. — as of 19 September 2026.

What is Honeywell Aerospace Inc.'s profit?

Honeywell Aerospace Inc. earned $0.3 B of net profit in the Jun 26 quarter, −69.4% year on year. Full-year FY25 profit was $2.7 B. The operating margin ran 12.8% in the latest quarter. — as of 19 September 2026.

What is Honeywell Aerospace Inc.'s market cap?

Honeywell Aerospace Inc.'s market capitalisation is $52.0 B at a stock price of $164. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 19 September 2026.

Does Honeywell Aerospace Inc. pay a dividend?

No — Honeywell Aerospace Inc. has declared no dividend per share in any of its last 10 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 19 September 2026.

Is Honeywell Aerospace Inc. growing?

Not right now — Honeywell Aerospace Inc.'s latest numbers are shrinking: latest-quarter revenue +5.4% year on year, profit −69.4%, and the margin −10.5 pp at 12.8%. The 2-year compound rates are 12.3% (revenue) and −3.3% (profit). The earnings engine currently reads: deteriorating — as of 19 September 2026.

How is Honeywell Aerospace Inc. performing?

Honeywell Aerospace Inc.'s latest readings are below. Its latest quarter's revenue rose 5.4% and profit fell 69.4% year on year. This describes what the data did, not a rating. — as of 19 September 2026.

Will Honeywell Aerospace Inc.'s stock price go up?

This page publishes no price forecast for Honeywell Aerospace Inc. What it measures instead: the stock price is $164. Direction is not something this site claims to know. — as of 19 September 2026.

Is the market betting against Honeywell Aerospace Inc.?

No — short interest is 1.5% of Honeywell Aerospace Inc.'s tradable float, about 1.0 days to cover at typical volumes. That is a low reading: the crowd is not positioned against this stock. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 19 September 2026.

What is Honeywell Aerospace Inc.'s capex?

Honeywell Aerospace Inc. spent $1.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.5 B. — as of 19 September 2026.

What is Honeywell Aerospace Inc.'s cash flow?

Honeywell Aerospace Inc. generated $3.7 B of operating cash flow in FY25 and $3.2 B of free cash flow after $0.5 B of capital spending. Reported profit that year was $2.7 B, so operating cash ran ahead of profit. — as of 19 September 2026.

Is Honeywell Aerospace Inc.'s profit real cash?

Yes — over the last 3 fiscal years, 109% of Honeywell Aerospace Inc.'s reported profit arrived as operating cash. In FY25, operating cash was $3.7 B against reported profit of $2.7 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 19 September 2026.

Where is Honeywell Aerospace Inc. in its business cycle?

Honeywell Aerospace Inc.'s FY25 operating margin was 19.3%, against a 3-year band of 19.3%–25.2%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 12.8%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 19 September 2026.

What could break the Honeywell Aerospace Inc. story?

Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 19 September 2026.

Is Honeywell Aerospace Inc. a stock worth studying right now?

This is not investment advice. The machine read: Honeywell Aerospace Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 19 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-19. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI